What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

MONDAY, June 2, 2025 (HealthDay News) — Wildfire smoke could make it harder for people with lung cancer to survive, a new ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

Lung cancer is the leading cause of cancer death in Western Australia, and is also the most common and one of the least ...

Researchers have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS ...